Nanion User Meeting USA 2018
Date and time
Location
Hyatt Regency Hotel
575 Memorial Dr. Cambridge, MA 02139Description
The 2018 Nanion User Meeting USA will be held at the Hyatt Regency hotel in Cambridge USA.
> Symposium will be organized on the 21th of June, where we welcome our users and collaboration partners to present their most recent data and research of interest.
- Speakers:
Keynote: Prof. Dr. Christine Beeton, Baylor College, Texas, USA.
Title: Targeting potassium channels in rheumatoid arthritis."
Keynote: Dr. Mark Estacion, Yale School of Medicine, USA
Title: Precision medicine targeting pain: progress finding treatments for specific NaV1.7 mutations."
Dr. Stephen Hess, Evotec, Hamburg Germany
Title: "Finding Nav1.1 Enhancers on the SyncroPatch 384PE"
Dr. David Jones, University of Wisconsin-Madison.
Title: "Targeting hERG K+ channel intracellular domains to manipulate channel function and cardiac repolarization"
Dr. Jun Chen, Genentech, Inc.
Title: "Molecular mechanisms for the activation and block of TRPA1 channel"
Dr. Al George Jr., Northwestern Medicine.
Title: "Decrypting variants of unknown significance in the channelopathies"
Dr. Shan Parikh, Vanderbilt University Medical Center.
Title: "High throughput investigation of contractile and electrophysiological properties of optically stimulated hiPSC-CM monolayers"
Dr. Stefan Braam, Ncardia.
Title: "iPSC derived cells in drug discovery and development"
Dr. Gary Aistrup, Masonic Medical Research Institute (MMRI), USA
Title: "CardioExcyte and SyncroPatch 384 High Throughput Assessment of Functional Abnormalities of Patient-Specific iPSC-CMs Harboring Multiple Mutations"
Dr. Jürgen Bosch, Case Western Reserve University.
Title: "Are two channels enough? The search for the missing piece."
Dr. Nicholas Last, Howard Hughes Medical Institute / Brandeis University.
Title: "Characterization of the curious pores of the Fluc fluoride channel with the Orbit Mini"
Dr. Scott MacDonnell, Regeneron Pharmaceuticals.
Title: “Evaluation of MYH7-R403Q Patient-Derived iPSC Cardiomyocytes as an In-Vitro Model of Hypertrophic Cardiomyopathy”
Dr. Sami Noujaim, University South Florida
Title: "Antiarrhythmic Potential of Antimalarial Aminoquinolines
Dr. Andrea Brüggemann, Nanion Technologies.
Title: "Applications of the SyncroPatch 384PE: Safety Pharmacology and more."
More information to follow:
Please register for our Newsletter or visit or Website "Nanion User Meeting USA 2018" for updates.
Call for posters:
Posters will be on display for the whole day on June 21th; submission is free of charge, please contact corina.bot@naniontech.com with a title and brief abstract before May 21st Note: Poster boards can accommodate 2ft by 2.5ft or 3x4ft posters.
Organized by
Nanion Technologies GmbH is a German Private Limited Company and was founded in 2002 as a spin-off from the Center for Nanoscience (CeNS) of the University of Munich.
Nanion Technologies supplies leading ion channel drug discovery and screening technologies: Our portfolio comprises patch clamp technology for sophisticated and high throughput applications (Port-a-Patch, Patchliner, SyncroPatch 384/768PE), impedance recordings (CardioExcyte 96), parallel bilayer recordings (Orbit mini & Orbit 16), and parallel membrane transporter protein recordings (SURFE²R N1 & SURFE²R 96SE).